AIFsh, a novel apoptosis-inducing factor (AIF) pro-apoptotic isoform with potential pathological relevance in human

Cécile Delettre1, Victor J Yuste, Rana S Moubarak

  • 1Apoptose et Système Immunitaire, CNRS-URA 1961 and Plateforme 5-Production de Protéines Recombinantes et d'Anticorps, Institut Pasteur, 25, rue du Dr. Roux, 75015 Paris, France.

Insights

Researchers discovered a new AIF isoform, AIFshort (AIFsh), which triggers caspase-independent cell death. This isoform

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Apoptosis-inducing Factor (AIF) is a key mediator of caspase-independent cell death.
  • AIF is encoded by a single gene on the X chromosome.
  • Two AIF isoforms, AIF and AIF-exB, were previously identified.

Purpose of the Study:

  • To identify novel isoforms of AIF.
  • To investigate the role of a newly discovered AIF isoform in cell death and cancer.

Main Methods:

  • Identification of a novel AIF isoform (AIFsh) using an alternate transcriptional start site.
  • Overexpression of AIFsh in HeLa cells.
  • Analysis of AIFsh effects on nuclear translocation, chromatin condensation, and DNA fragmentation.
  • Assessment of AIFsh regulation in various tumor cells and after gamma-irradiation.

Main Results:

  • A third AIF isoform, AIFshort (AIFsh), was identified, comprising the C-terminal domain (amino acids 353-613).
  • AIFsh overexpression induces nuclear translocation and caspase-independent cell death, including chromatin condensation and DNA fragmentation.
  • The N-terminal 352 amino acids of AIF are not essential for its apoptotic activity.
  • AIFsh is downregulated in multiple tumor types but upregulated by gamma irradiation.

Conclusions:

  • AIFsh is a novel pro-apoptotic AIF isoform.
  • The apoptotic function of AIF does not require its N-terminal domain.
  • AIFsh plays a role in tumor suppression and its dysregulation is implicated in cancer formation.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...